Skip to content

Serious Games Rehabilitation Programme to Treat Gait and Balance Disorders in PD Patients

Serious Games Rehabilitation Programme to Treat Gant and Balance Disorders in Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03560089
Acronym
PARKGAME-II
Enrollment
25
Registered
2018-06-18
Start date
2018-07-18
Completion date
2021-12-06
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease, Gait, Rehabilitation, Serious game

Brief summary

To test the effects of a serious game rehabilitation programme in 50 patients with Parkinson's disease with gait and balance disorders in a randomised controlled study

Interventions

DEVICESerious game

Serious game with movements

DEVICEPlacebo serious game

Serious game without movement

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinded assessment of video

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease * Gait and balance disorders resistant to dopaminergic medication

Exclusion criteria

* dementia * contra-indication to magnetic resonance imaging

Design outcomes

Primary

MeasureTime frame
Duration of the time-up-go testchange between baseline and at 6 weeks

Secondary

MeasureTime frame
Step lengthchange between baseline and at 6 weeks
step velocitychange between baseline and at 6 weeks
Movement disorders Unified Parkinson's disease rating scalechange between baseline and at 6 weeks
freezing of gait questionnairechange between baseline and at 6 weeks
Duration of the time-up-go testchange between baseline and at 18 weeks
gait and balance scalechange between baseline and at 6 weeks
Montreal Cognitive Assessmentchange between baseline and at 6 weeks
Magnetic resonance imagingchange between baseline and at 6 weeks
Parkinson's disease quality of life scalechange between baseline and at 6 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026